Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jwala P. Sivaccumar"'
Autor:
Jwala P. Sivaccumar, Emanuela Iaccarino, Angela Oliver, Maria Cantile, Pierpaolo Olimpieri, Antonio Leonardi, Menotti Ruvo, Annamaria Sandomenico
Publikováno v:
Pharmaceuticals, Vol 16, Iss 8, p 1130 (2023)
Drug development in recent years is increasingly focused on developing personalized treatments based on blocking molecules selective for therapeutic targets specifically present in individual patients. In this perspective, the specificity of therapeu
Externí odkaz:
https://doaj.org/article/3af5e9b380eb4d94a97cfec3cd903d04
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Infectious diseases, caused by pathogenic microorganisms, are capable of affecting crises. In addition to persistent infectious diseases such as malaria and dengue fever, the vicious outbreaks of infectious diseases such as Neocon, Ebola and SARS-CoV
Externí odkaz:
https://doaj.org/article/c861207af3a14358b655d857fe9046bc
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 17, p 6324 (2020)
Antibodies and antibody-derived molecules are continuously developed as both therapeutic agents and key reagents for advanced diagnostic investigations. Their application in these fields has indeed greatly expanded the demand of these molecules and t
Externí odkaz:
https://doaj.org/article/565f3288304b491993653af1abd2c92c
Autor:
Hailong Guo, Bomsoo Cho, Paul R. Hinton, Sijia He, Yongjun Yu, Ashwin Kumar Ramesh, Jwala Priyadarsini Sivaccumar, Zhiqiang Ku, Kristen Campo, Sarah Holland, Sameer Sachdeva, Christopher Mensch, Mohamed Dawod, Annalis Whitaker, Philip Eisenhauer, Allison Falcone, Rebekah Honce, Jason W. Botten, Stephen F. Carroll, Bruce A. Keyt, Andrew W. Womack, William R. Strohl, Kai Xu, Ningyan Zhang, Zhiqiang An, Sha Ha, John W. Shiver, Tong-Ming Fu
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 2 (2023)
The capacity of SARS-CoV-2 to evolve poses challenges to conventional prevention and treatment options such as vaccination and monoclonal antibodies, as they rely on viral receptor binding domain (RBD) sequences from previous strains. Additionally, a
Externí odkaz:
https://doaj.org/article/b32daa709614466280c100d037969216
Autor:
Jwala Priyadarsini Sivaccumar, Antonio Leonardi, Emanuela Iaccarino, Giusy Corvino, Luca Sanguigno, Angela Chambery, Rosita Russo, Mariangela Valletta, Debora Latino, Domenica Capasso, Nunzianna Doti, Menotti Ruvo, Annamaria Sandomenico
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 6, p 3166 (2021)
Background: Monoclonal antibodies (mAbs) against cancer biomarkers are key reagents in diagnosis and therapy. One such relevant biomarker is a preferentially expressed antigen in melanoma (PRAME) that is selectively expressed in many tumors. Knowing
Externí odkaz:
https://doaj.org/article/62bd881b6be84c59a7893ef4b834978f